Aprecap 125/80 Capsule is a prescription medication manufactured by Glenmark Pharmaceuticals Ltd. It is primarily used to prevent chemotherapy-induced nausea and vomiting (CINV) in adults and adolescents aged 12 years and older.
Category | Antiemetic |
Brand | Glenmark |
Ingredient | Aprepitant |
Prescription Required | Yes |
Strength | 125/80 mg |
Package | 1 & 2 Tablets |
Aprecap 125/80 capsules, which contain the active ingredient Aprepitant, work by blocking the neurokinin-1 (NK1) receptor in the brain. Neurokinin is a substance that plays a key role in the process of nausea and vomiting, particularly in response to chemotherapy. By inhibiting the NK1 receptors, Aprepitant prevents the signals that trigger nausea and vomiting, which are common side effects of chemotherapy..
Aprecap 125/80 capsules offer significant benefits, particularly for patients undergoing chemotherapy. The medication is highly effective in preventing chemotherapy-induced nausea and vomiting (CINV), which are among the most common and debilitating side effects of chemotherapy..
The most common side effects of 125/80 capsules are
• Headache
• Fatigue
• Loss of appetite
• Constipation
• Indigestion
• Dizziness
• Hiccups
• Elevated liver enzymes
Other side effects of 125/80 capsules can include
1. Allergic reactions (such as rash, itching, or swelling)
2. Stomach pain or discomfort
3. Diarrhea or nausea
4. Elevated blood pressure
5. Fatigue or drowsiness
6. Mood changes (such as irritability or anxiety)
7. Trouble sleeping (insomnia)
8. Shortness of breath or difficulty breathing (rare)
precap 125/80 capsules (Aprepitant) should not be taken by certain individuals due to potential risks. Pregnant women should avoid using Aprecap, as its safety during pregnancy has not been established, and it should only be used if the potential benefits outweigh the risks, under the guidance of a healthcare provider. Breastfeeding mothers are also advised not to use the medication unless specifically instructed by their doctor, as it is unclear whether Aprecap passes into breast milk.
Aprecap 125/80 capsules should be taken exactly as prescribed by your healthcare provider. Typically, the medication is taken as part of a three-day regimen to prevent chemotherapy-induced nausea and vomiting. On Day 1, take one 125 mg capsule about 1 hour before chemotherapy. On Days 2 and 3, take one 80 mg capsule each morning. Aprecap can be taken with or without food, but it should be swallowed whole with a glass of water—do not chew or crush the capsules.
There are no reviews yet.